Study S001118

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06759701
Study type: INTERVENTIONAL
Phase: EARLY_PHASE1
Masking: NONE
Status: RECRUITING
Enrollment: 30
Start: 2025-07-02
Primary completion: 2026-12-31
Lead sponsor: M.D. Anderson Cancer Center
Conditions: Diabetes; Prostate Cancer
Interventions: DRUG:Tirzepatide
Results posted: FALSE
Secondary identifiers: OTHER:NCI-2024-10696

Registered primary outcomes

Safety and Adverse Events (AEs) [Through study completion; an average of 1 year]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.